Bausch Health Companies (NYSE:BHC) has made headlines with its definitive agreement to acquire liver-focused biotech Durect Corporation (NASDAQ:DRRX) for...
Bausch Health Companies (NYSE:BHC) has made headlines with its definitive agreement to acquire liver-focused biotech Durect Corporation (NASDAQ:DRRX) for...